Nanoparticle-Based Approaches towards the Treatment of Atherosclerosis
Atherosclerosis, being an inflammation-associated disease, represents a considerable healthcare problem. Its origin remains poorly understood, and at the same time, it is associated with extensive morbidity and mortality worldwide due to myocardial infarctions and strokes. Unfortunately, drugs are u...
Main Authors: | Artur Y. Prilepskii, Nikita S. Serov, Daniil V. Kladko, Vladimir V. Vinogradov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/11/1056 |
Similar Items
-
Nanomaterial Shape Influence on Cell Behavior
by: Daniil V. Kladko, et al.
Published: (2021-05-01) -
Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis
by: Haikun Liu, et al.
Published: (2022-02-01) -
Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis
by: Li Zhu, et al.
Published: (2023-08-01) -
EGFP-EGF1-conjugated poly(lactic-co-glycolic acid) nanoparticles, a new diagnostic tool and drug carrier for atherosclerosis
by: Wu Z, et al.
Published: (2019-04-01) -
Metal Nanoparticles in Atherosclerosis: Applications and Potential Toxicity
by: Fatemeh Imanparast, et al.
Published: (2015-09-01)